497 related articles for article (PubMed ID: 30777898)
21. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
[TBL] [Abstract][Full Text] [Related]
22. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
O'Brien S; Fothergill JL
FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314
[TBL] [Abstract][Full Text] [Related]
23. Staphylococcus aureus Impacts Pseudomonas aeruginosa Chronic Respiratory Disease in Murine Models.
Cigana C; Bianconi I; Baldan R; De Simone M; Riva C; Sipione B; Rossi G; Cirillo DM; Bragonzi A
J Infect Dis; 2018 Mar; 217(6):933-942. PubMed ID: 29216403
[TBL] [Abstract][Full Text] [Related]
24. Friends or enemies? The complicated relationship between Pseudomonas aeruginosa and Staphylococcus aureus.
Yung DBY; Sircombe KJ; Pletzer D
Mol Microbiol; 2021 Jul; 116(1):1-15. PubMed ID: 33576132
[TBL] [Abstract][Full Text] [Related]
25. Co-infection with Pseudomonas aeruginosa impacts virulence of Staphylococcus aureus and intensifies the severity of infection.
Shoaib A; Lone NA; Yi X
Pak J Pharm Sci; 2020 Sep; 33(5):1933-1937. PubMed ID: 33824098
[TBL] [Abstract][Full Text] [Related]
26. The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.
Ramsay KA; Sandhu H; Geake JB; Ballard E; O'Rourke P; Wainwright CE; Reid DW; Kidd TJ; Bell SC
J Cyst Fibros; 2017 Jan; 16(1):70-77. PubMed ID: 27515017
[TBL] [Abstract][Full Text] [Related]
27. The Yin and Yang of
Scott JE; O'Toole GA
J Bacteriol; 2019 Jun; 201(11):. PubMed ID: 30885933
[TBL] [Abstract][Full Text] [Related]
28. Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India.
Arvind B; Medigeshi GR; Kapil A; Xess I; Singh U; Lodha R; Kabra SK
Indian J Med Res; 2020 Jan; 151(1):65-70. PubMed ID: 32134016
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa Production of Hydrogen Cyanide Leads to Airborne Control of Staphylococcus aureus Growth in Biofilm and
Létoffé S; Wu Y; Darch SE; Beloin C; Whiteley M; Touqui L; Ghigo JM
mBio; 2022 Oct; 13(5):e0215422. PubMed ID: 36129311
[TBL] [Abstract][Full Text] [Related]
31. Evolution of metabolic divergence in Pseudomonas aeruginosa during long-term infection facilitates a proto-cooperative interspecies interaction.
Frydenlund Michelsen C; Hossein Khademi SM; Krogh Johansen H; Ingmer H; Dorrestein PC; Jelsbak L
ISME J; 2016 Jun; 10(6):1323-36. PubMed ID: 26684729
[TBL] [Abstract][Full Text] [Related]
32. Molecular Mechanisms of
Biswas L; Götz F
Front Cell Infect Microbiol; 2021; 11():824042. PubMed ID: 35071057
[TBL] [Abstract][Full Text] [Related]
33. The social life of microbes in chronic infection.
Ibberson CB; Whiteley M
Curr Opin Microbiol; 2020 Feb; 53():44-50. PubMed ID: 32145635
[TBL] [Abstract][Full Text] [Related]
34. Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients.
Fugère A; Lalonde Séguin D; Mitchell G; Déziel E; Dekimpe V; Cantin AM; Frost E; Malouin F
PLoS One; 2014; 9(1):e86705. PubMed ID: 24466207
[TBL] [Abstract][Full Text] [Related]
35. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms.
Orazi G; Jean-Pierre F; O'Toole GA
J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077
[TBL] [Abstract][Full Text] [Related]
36. Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.
Somayaji R; Waddell B; Workentine ML; Surette MG; Brager NP; Rabin HR; Parkins MD
BMC Pulm Med; 2015 Nov; 15():138. PubMed ID: 26542115
[TBL] [Abstract][Full Text] [Related]
37. A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study.
Maliniak ML; Stecenko AA; McCarty NA
J Cyst Fibros; 2016 May; 15(3):350-6. PubMed ID: 26610860
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
Smyth AR; Walters S
Cochrane Database Syst Rev; 2014 Nov; (11):CD001912. PubMed ID: 25419599
[TBL] [Abstract][Full Text] [Related]
39. Sustained Coinfections with
Fischer AJ; Singh SB; LaMarche MM; Maakestad LJ; Kienenberger ZE; Peña TA; Stoltz DA; Limoli DH
Am J Respir Crit Care Med; 2021 Feb; 203(3):328-338. PubMed ID: 32750253
[No Abstract] [Full Text] [Related]
40. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
Smyth AR; Walters S
Cochrane Database Syst Rev; 2012 Dec; 12():CD001912. PubMed ID: 23235585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
